Company Overview and News
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
Sandspring Resources is an out-of-the-money call option on gold with a $1,300 strike price and no expiration date.
The typical retail investor usually operates from a position of weakness relative to Big Money since they do not have the required credentials needed to participate in private placement deals.
The cost of opportunity has been rising overtime, and investors may want to look elsewhere to capitalize on the nascent bull market in gold.
DENVER, COLORADO and VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 3, 2017) - Sandspring Resources Ltd. (TSX VENTURE:SSP)(OTCQX:SSPXF) ("Sandspring" or the "Company") is pleased to announce it has qualified for trading on the OTCQX® Best Market, operated by OTC Markets Group.
NEW YORK, May 3, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Sandspring Resources Ltd. (TSX-V: SSP; OTCQX: SSPXF), a Canadian junior mining company, has qualified to trade on the OTCQX® Best Market. Sandspring Resources upgraded to OTCQX from the Pink® market.
Below is my list of the top gold & silver mining stock takeover targets. None of them are producers, but they all have very lucrative properties. Plus, they are all undervalued. Most of them have very advanced projects.
DENVER, COLORADO and VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2017) - Sandspring Resources Ltd. (TSX VENTURE:SSP)(OTCQX:SSPXF) ("Sandspring" or the "Company") is pleased to announce the appointment of Gordon Keep to the board of directors ("Board") of the Company.
GoldMining stock is valued like as if it’s 2015 again, and it has the potential to be a 5-bagger under the right gold setup.
DENVER, COLORADO and VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 23, 2017) - Sandspring Resources Ltd. (TSX VENTURE:SSP)(OTC PINK:SSPXF) ("Sandspring" or the "Company") is pleased to report the maiden mineral resource estimate ("Resource Estimate") for its discovery at Sona Hill, deposit located 5 km southeast of the Toroparu Gold Project ("Toroparu")(1) in Guyana, South America.
MADRID Feb 13 The Bank of Spain said on Monday that three officials would resign after the Spanish High Court named them on Monday as suspects in an investigation into Bankia's disputed flotation in 2011.
Feb 13 CBS Corp's airing of the 59th Annual Grammy Awards drew 26.05 million viewers on Sunday night, up 4 percent from last year, according to Nielsen data.
* BONTERRA RESOURCES INC SAYS HAS AGREED TO INCREASE OFFERING SIZE OF PURCHASED SECURITIES FROM $12.9 MILLION TO $14 MILLION IN GROSS PROCEEDS Source text for Eikon: Further company coverage:
* Sandspring Resources Ltd - Appointment of Jessica Van Den Akker as Chief Financial Officer of company Source text for Eikon: Further company coverage:
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...